Home OrbusNeich

OrbusNeich

OrbusNeich Medical and P+P Products & Features Partnership

OrbusNeich notes P+F will bring to the partnership a series of innovative minimally invasive heart valve products premounted on the delivery system using P+F's proprietary dry valve technology.

OrbusNeich’s COMBO™ Dual Therapy Stent Demonstrates Non-inferiority vs the Market Leading XIENCE™ Everolimus Eluting Stent

New results from the HARMONEE Japan/US Registration Trial, reported by OrbusNeich today in the First Report Investigations session at the 29th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, demonstrate that the COMBO™ Dual Therapy Stent (DTS) compares favorably to the market leading option for treating patients with significant ischemic heart disease.